Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in China

BACKGROUND: The advent of direct-acting agents (DAAs) has improved treatment of HCV in HIV co-infection, but may be limited by primary drug resistance. This study reports the prevalence of natural polymorphisms conferring resistance to NS3/4A protease inhibitors and NS5B polymerase inhibitors in tre...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Zhou, Kali, Liang, Zhiwei, Wang, Charles, Hu, Fengyu, Ning, Chuanyi, Lan, Yun, Tang, Xiaoping, Tucker, Joseph D., Cai, Weiping
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2016
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4920402/
https://ncbi.nlm.nih.gov/pubmed/27341031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0157438
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk